Liraglutide exerts an anti-inflammatory action in obese patients with type 2 diabetes
Introduction. Liraglutide (L) is the analogue of human glucagon-like peptide 1 which stimulates glucose-dependent insulin secretion and can modify the level of inflammatory biomarkers.
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2019-09-01
|
Series: | Romanian Journal of Internal Medicine |
Subjects: | |
Online Access: | https://doi.org/10.2478/rjim-2019-0003 |